INSULIN DOSE REDUCTIONS IN THE INPATIENT SETTING: HOW MUCH IS ENOUGH?

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Endocrine Practice

• Publication date

  2018-03-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.4158/EP-2017-0188PMID 29561191
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of basal‐bolus insulin regimens in the inpatient management of non‐critically ill patients with type 2 diabetes: A systematic review and meta‐analysis

  2017cited by this paper
• Sliding-scale insulin used for blood glucose control: a meta-analysis of randomized controlled trials.

  2015cited by this paper
• Importance of Perioperative Glycemic Control in General Surgery: A Report From the Surgical Care and Outcomes Assessment Program

  2013cited by this paper
• Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis.

  2012cited by this paper
• American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

  2009cited by this paper
• Intensive versus conventional glucose control in critically ill patients.

  2009cited by this paper
• Intensive insulin therapy and pentastarch resuscitation in severe sepsis.

  2008cited by this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cited by this paper
• Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.

  2002cited by this paper

• Inpatient diabetes management

  2024cites this paper